NY-ESO-1 protein expression and humoral immune responses in prostate cancer (Q47816351)

5 February 2018

title

NY-ESO-1 protein expression and humoral immune responses in prostate cancer (English)

1 reference

5 February 2018

1 reference

1

Alexander Fosså

1 reference

5 February 2018

5

Gustav Gaudernack

1 reference

5 February 2018

3

Sophie D Fosså

1 reference

5 February 2018

6

Erlend B Smeland

1 reference

5 February 2018

Aasmund Berner

2

1 reference

5 February 2018

Eivor Hernes

series ordinal

4

1 reference

5 February 2018

publication date

1 June 2004

1 reference

5 February 2018

published in

The Prostate

1 reference

5 February 2018

volume

59

1 reference

5 February 2018

issue

4

1 reference

5 February 2018

page(s)

440-447

1 reference

5 February 2018

Identification of MHC class II-restricted tumor antigens recognized by CD4+ T cells

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

LAGE-1, a new gene with tumor specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

21 January 2018

Anticancer antibodies

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

Fingerprinting the circulating repertoire of antibodies from cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

MAGE-B5, MAGE-B6, MAGE-C2, andMAGE-C3: four new members of theMAGE family with tumor-specific expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

Breakdown of Th cell immune responses and steroidogenic CYP11A1 expression in CD4+ T cells in a murine model implanted with B16 melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20025

21 January 2018

Identifiers

DOI

10.1002/PROS.20025

1 reference

5 February 2018

1 reference

5 February 2018